| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | QS5F6VTS0O |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Connective tissue growth factor inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Muscular Dystrophy, Duchenne | 3 | D020388 | ClinicalTrials |
| Pancreatic Neoplasms | 3 | D010190 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 3 | D054990 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Diabetes Mellitus | 1 | D003920 | ClinicalTrials |
| Glomerulosclerosis, Focal Segmental | 1 | D005923 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 946415-13-0 |
| ChEMBL | CHEMBL2109377 |
| FDA SRS | QS5F6VTS0O |
| Guide to Pharmacology | 8928 |
CONTENTS